Literature DB >> 9812073

Implementation of a computerized cardiovascular information system in a private hospital setting.

G S Taylor1, J B Muhlestein, G S Wagner, T L Bair, P Li, J L Anderson.   

Abstract

BACKGROUND: The use of clinical databases improves quality of care, reduces operating costs, helps secure managed care contracts, and assists in clinical research. Because of the large physician input required to maintain these systems, private institutions have often found them difficult to implement. At LDS Hospital in Salt Lake City, Utah, we developed a cardiovascular information system (LDS-CIS) patterned after the Duke University Cardiovascular Database and designed for ease of use in a private hospital setting.
METHODS: Features of the LDS-CIS include concise single-page report forms, a relational database engine that is easily queried, automatic generation of final procedure reports, and merging of all data with the hospital's existing information system. So far, data from more than 14,000 patients have been entered.
RESULTS: LDS-CIS provides access to data for research to improve patient care. For example, by using data generated by LDS-CIS, the policy requiring surgical backup during percutaneous transluminal coronary angioplasty was eliminated, resulting in no increased patient risk while saving nearly $1 million in 1 year. LDS-CIS generates physician feedback reports documenting performance compared with peers. This physician self-evaluation has standardized and improved care. Information from LDS-CIS has been instrumental in securing and maintaining managed care contracts. LDS-CIS risk analysis provides physicians with outcomes data specific to their current patient's demographics and level of disease to assist in point of care decisions.
CONCLUSION: The use of LDS-CIS in the routine operations of LDS Hospital heart services has been found to be feasible, beneficial, and cost-effective.

Entities:  

Mesh:

Year:  1998        PMID: 9812073     DOI: 10.1016/s0002-8703(98)70123-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Implementing Single Source: the STARBRITE proof-of-concept study.

Authors:  Rebecca Kush; Liora Alschuler; Roberto Ruggeri; Sally Cassells; Nitin Gupta; Landen Bain; Karen Claise; Monica Shah; Meredith Nahm
Journal:  J Am Med Inform Assoc       Date:  2007-06-28       Impact factor: 4.497

2.  Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography.

Authors:  Benjamin D Horne; Heidi T May; Jeffrey L Anderson; Abdallah G Kfoury; Beau M Bailey; Brian S McClure; Dale G Renlund; Donald L Lappé; John F Carlquist; Patrick W Fisher; Robert R Pearson; Tami L Bair; Ted D Adams; Joseph B Muhlestein
Journal:  Am J Cardiol       Date:  2008-07-10       Impact factor: 2.778

3.  HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

Authors:  Seth S Martin; Arif A Khokhar; Heidi T May; Krishnaji R Kulkarni; Michael J Blaha; Parag H Joshi; Peter P Toth; Joseph B Muhlestein; Jeffrey L Anderson; Stacey Knight; Yan Li; John A Spertus; Steven R Jones
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

4.  Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation.

Authors:  Stacey Knight; Raymond O McCubrey; Zhong Yuan; Scott C Woller; Benjamin D Horne; T Jared Bunch; Viet T Le; Roger M Mills; Joseph B Muhlestein
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-02-25

5.  Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.

Authors:  Jeffrey L Anderson; Benjamin D Horne; Nicola J Camp; Joseph B Muhlestein; Paul N Hopkins; Lisa A Cannon-Albright; Chrissa P Mower; James J Park; Jessica L Clarke; Zachary P Nicholas; Jason T McKinney; John F Carlquist
Journal:  Am Heart J       Date:  2010-08       Impact factor: 4.749

6.  Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smoking.

Authors:  Benjamin D Horne; Elizabeth R Hauser; Liyong Wang; Joseph B Muhlestein; Jeffrey L Anderson; John F Carlquist; Svati H Shah; William E Kraus
Journal:  Ann Hum Genet       Date:  2009-08-25       Impact factor: 1.670

7.  A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃+IDL]).

Authors:  Heidi T May; John R Nelson; Krishnaji R Kulkarni; Jeffrey L Anderson; Benjamin D Horne; Tami L Bair; Joseph B Muhlestein
Journal:  Lipids Health Dis       Date:  2013-04-26       Impact factor: 3.876

8.  External validation of integrated genetic-epigenetic biomarkers for predicting incident coronary heart disease.

Authors:  Meeshanthini V Dogan; Stacey Knight; Timur K Dogan; Kirk U Knowlton; Robert Philibert
Journal:  Epigenomics       Date:  2021-06-21       Impact factor: 4.357

9.  Long-Term Implications of Abnormal Left Ventricular Strain During Sepsis.

Authors:  Sarah J Beesley; Jeff Sorensen; Allan J Walkey; Joseph E Tonna; Michael J Lanspa; Ellie Hirshberg; Colin K Grissom; Benjamin D Horne; Rebecca Burk; Theodore P Abraham; Robert Paine; Samuel M Brown
Journal:  Crit Care Med       Date:  2021-04-01       Impact factor: 9.296

10.  Antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative study.

Authors:  Stacey Knight; Winslow Klaskala; Scott C Woller; Benjamin D Horne; T Jared Bunch; Viet T Le; Roger M Mills; Joseph B Muhlestein
Journal:  Cardiol Res Pract       Date:  2015-01-08       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.